HCPCS Q Codes – Temporary Codes

• Q0035 – Cardiokymography
• Q0081 – Infusion therapy, using other than chemotherapeutic drugs, per visit
• Q0083 – Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit
• Q0084 – Chemotherapy administration by infusion technique only, per visit
• Q0085 – Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit
• Q0091 – Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory
• Q0092 – Set-up portable x-ray equipment
• Q0111 – Wet mounts, including preparations of vaginal, cervical or skin specimens
• Q0112 – All potassium hydroxide (koh) preparations
• Q0113 – Pinworm examinations
• Q0114 – Fern test
• Q0115 – Post-coital direct, qualitative examinations of vaginal or cervical mucous
• Q0138 – Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
• Q0139 – Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)
• Q0144 – Azithromycin dihydrate, oral, capsules/powder, 1 gram
• Q0155 – Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0161 – Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0162 – Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0163 – Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen
• Q0164 – Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0166 – Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
• Q0167 – Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0169 – Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0173 – Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0175 – Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0177 – Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0180 – Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
• Q0181 – Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0224 – Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg
• Q0234 – Injection, tocilizumab-bavi, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation only, 1 mg
• Q0235 – Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg
• Q0237 – Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
• Q0238 – Injection, tocilizumab-aazg, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
• Q0249 – Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
• Q0477 – Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only
• Q0478 – Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type
• Q0479 – Power module for use with electric or electric/pneumatic ventricular assist device, replacement only
• Q0480 – Driver for use with pneumatic ventricular assist device, replacement only
• Q0481 – Microprocessor control unit for use with electric ventricular assist device, replacement only
• Q0482 – Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only
• Q0483 – Monitor/display module for use with electric ventricular assist device, replacement only
• Q0484 – Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only
• Q0485 – Monitor control cable for use with electric ventricular assist device, replacement only
• Q0486 – Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only
• Q0487 – Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only
• Q0488 – Power pack base for use with electric ventricular assist device, replacement only
• Q0489 – Power pack base for use with electric/pneumatic ventricular assist device, replacement only
• Q0490 – Emergency power source for use with electric ventricular assist device, replacement only
• Q0491 – Emergency power source for use with electric/pneumatic ventricular assist device, replacement only
• Q0492 – Emergency power supply cable for use with electric ventricular assist device, replacement only
• Q0493 – Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only
• Q0494 – Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only
• Q0495 – Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only
• Q0496 – Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
• Q0497 – Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only
• Q0498 – Holster for use with electric or electric/pneumatic ventricular assist device, replacement only
• Q0499 – Belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only
• Q0500 – Filters for use with electric or electric/pneumatic ventricular assist device, replacement only
• Q0501 – Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only
• Q0502 – Mobility cart for pneumatic ventricular assist device, replacement only
• Q0503 – Battery for pneumatic ventricular assist device, replacement only, each
• Q0504 – Power adapter for pneumatic ventricular assist device, replacement only, vehicle type
• Q0506 – Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
• Q0507 – Miscellaneous supply or accessory for use with an external ventricular assist device
• Q0508 – Miscellaneous supply or accessory for use with an implanted ventricular assist device
• Q0509 – Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a
• Q0510 – Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
• Q0511 – Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period
• Q0512 – Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period
• Q0513 – Pharmacy dispensing fee for inhalation drug(s); per 30 days
• Q0514 – Pharmacy dispensing fee for inhalation drug(s); per 90 days
• Q0515 – Injection, sermorelin acetate, 1 microgram
• Q0521 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription
• Q1004 – New technology intraocular lens category 4 as defined in federal register notice
• Q1005 – New technology intraocular lens category 5 as defined in federal register notice
• Q2004 – Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml
• Q2009 – Injection, fosphenytoin, 50 mg phenytoin equivalent
• Q2026 – Injection, radiesse, 0.1 ml
• Q2028 – Injection, sculptra, 0.5 mg
• Q2034 – Influenza virus vaccine, split virus, for intramuscular use (agriflu)
• Q2035 – Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)
• Q2036 – Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)
• Q2037 – Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)
• Q2038 – Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)
• Q2039 – Influenza virus vaccine, not otherwise specified
• Q2041 – Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
• Q2042 – Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
• Q2043 – Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
• Q2049 – Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg
• Q2050 – Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
• Q2052 – Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)
• Q2053 – Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
• Q2054 – Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
• Q2055 – Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
• Q2056 – Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
• Q2057 – Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose
• Q2058 – Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
• Q3001 – Radioelements for brachytherapy, any type, each
• Q3014 – Telehealth originating site facility fee
• Q3027 – Injection, interferon beta-1a, 1 mcg for intramuscular use
• Q3028 – Injection, interferon beta-1a, 1 mcg for subcutaneous use
• Q3031 – Collagen skin test
• Q4001 – Casting supplies, body cast adult, with or without head, plaster
• Q4002 – Cast supplies, body cast adult, with or without head, fiberglass
• Q4003 – Cast supplies, shoulder cast, adult (11 years +), plaster
• Q4004 – Cast supplies, shoulder cast, adult (11 years +), fiberglass
• Q4005 – Cast supplies, long arm cast, adult (11 years +), plaster
• Q4006 – Cast supplies, long arm cast, adult (11 years +), fiberglass
• Q4007 – Cast supplies, long arm cast, pediatric (0-10 years), plaster
• Q4008 – Cast supplies, long arm cast, pediatric (0-10 years), fiberglass
• Q4009 – Cast supplies, short arm cast, adult (11 years +), plaster
• Q4010 – Cast supplies, short arm cast, adult (11 years +), fiberglass
• Q4011 – Cast supplies, short arm cast, pediatric (0-10 years), plaster
• Q4012 – Cast supplies, short arm cast, pediatric (0-10 years), fiberglass
• Q4013 – Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), plaster
• Q4014 – Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass
• Q4015 – Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), plaster
• Q4016 – Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), fiberglass
• Q4017 – Cast supplies, long arm splint, adult (11 years +), plaster
• Q4018 – Cast supplies, long arm splint, adult (11 years +), fiberglass
• Q4019 – Cast supplies, long arm splint, pediatric (0-10 years), plaster
• Q4020 – Cast supplies, long arm splint, pediatric (0-10 years), fiberglass
• Q4021 – Cast supplies, short arm splint, adult (11 years +), plaster
• Q4022 – Cast supplies, short arm splint, adult (11 years +), fiberglass
• Q4023 – Cast supplies, short arm splint, pediatric (0-10 years), plaster
• Q4024 – Cast supplies, short arm splint, pediatric (0-10 years), fiberglass
• Q4025 – Cast supplies, hip spica (one or both legs), adult (11 years +), plaster
• Q4026 – Cast supplies, hip spica (one or both legs), adult (11 years +), fiberglass
• Q4027 – Cast supplies, hip spica (one or both legs), pediatric (0-10 years), plaster
• Q4028 – Cast supplies, hip spica (one or both legs), pediatric (0-10 years), fiberglass
• Q4029 – Cast supplies, long leg cast, adult (11 years +), plaster
• Q4030 – Cast supplies, long leg cast, adult (11 years +), fiberglass
• Q4031 – Cast supplies, long leg cast, pediatric (0-10 years), plaster
• Q4032 – Cast supplies, long leg cast, pediatric (0-10 years), fiberglass
• Q4033 – Cast supplies, long leg cylinder cast, adult (11 years +), plaster
• Q4034 – Cast supplies, long leg cylinder cast, adult (11 years +), fiberglass
• Q4035 – Cast supplies, long leg cylinder cast, pediatric (0-10 years), plaster
• Q4036 – Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass
• Q4037 – Cast supplies, short leg cast, adult (11 years +), plaster
• Q4038 – Cast supplies, short leg cast, adult (11 years +), fiberglass
• Q4039 – Cast supplies, short leg cast, pediatric (0-10 years), plaster
• Q4040 – Cast supplies, short leg cast, pediatric (0-10 years), fiberglass
• Q4041 – Cast supplies, long leg splint, adult (11 years +), plaster
• Q4042 – Cast supplies, long leg splint, adult (11 years +), fiberglass
• Q4043 – Cast supplies, long leg splint, pediatric (0-10 years), plaster
• Q4044 – Cast supplies, long leg splint, pediatric (0-10 years), fiberglass
• Q4045 – Cast supplies, short leg splint, adult (11 years +), plaster
• Q4046 – Cast supplies, short leg splint, adult (11 years +), fiberglass
• Q4047 – Cast supplies, short leg splint, pediatric (0-10 years), plaster
• Q4048 – Cast supplies, short leg splint, pediatric (0-10 years), fiberglass
• Q4049 – Finger splint, static
• Q4050 – Cast supplies, for unlisted types and materials of casts
• Q4051 – Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)
• Q4074 – Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms
• Q4081 – Injection, epoetin alfa, 100 units (for esrd on dialysis)
• Q4082 – Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)
• Q4101 – Apligraf, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4102 – Oasis wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4103 – Oasis burn matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4104 – Integra bilayer matrix wound dressing (bmwd), per square centimeter (add-on, list separately in addition to primary procedure)
• Q4105 – Integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4107 – Graftjacket, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4108 – Integra matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4110 – Primatrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4111 – Gammagraft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4112 – Cymetra, injectable, 1 cc
• Q4113 – Graftjacket xpress, injectable, 1 cc
• Q4114 – Integra flowable wound matrix, injectable, 1 cc
• Q4115 – Alloskin, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4116 – Alloderm, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4117 – Hyalomatrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4118 – Matristem micromatrix, 1 mg
• Q4121 – Theraskin, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4122 – Dermacell, dermacell awm or dermacell awm porous, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4123 – Alloskin rt, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4124 – Oasis ultra tri-layer wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4125 – Arthroflex, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4126 – Memoderm, dermaspan, tranzgraft or integuply, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4127 – Talymed, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4128 – Flex hd, or allopatch hd, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4130 – Strattice tm, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4132 – Grafix core and grafixpl core, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4133 – Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4134 – Hmatrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4135 – Mediskin, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4136 – Ez-derm, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4137 – Amnioexcel, amnioexcel plus or biodexcel, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4138 – Biodfence dryflex, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4139 – Amniomatrix or biodmatrix, injectable, 1 cc
• Q4140 – Biodfence, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4141 – Alloskin ac, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4142 – Xcm biologic tissue matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4143 – Repriza, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4145 – Epifix, injectable, 1 mg
• Q4146 – Tensix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4147 – Architect, architect px, or architect fx, extracellular matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4148 – Neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4149 – Excellagen, 0.1 cc
• Q4150 – Allowrap ds or dry, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4151 – Amnioband or guardian, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4152 – Dermapure, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4153 – Dermavest and plurivest, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4154 – Biovance, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4155 – Neoxflo or clarixflo, 1 mg
• Q4156 – Neox 100 or clarix 100, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4157 – Revitalon, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4158 – Kerecis omega3, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4159 – Affinity, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4160 – Nushield, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4161 – Bio-connekt wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4162 – Woundex flow, bioskin flow, 0.5 cc
• Q4163 – Woundex, bioskin, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4164 – Helicoll, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4165 – Keramatrix or kerasorb, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4166 – Cytal, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4167 – Truskin, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4168 – Amnioband, 1 mg
• Q4169 – Artacent wound, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4170 – Cygnus, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4171 – Interfyl, 1 mg
• Q4173 – Palingen or palingen xplus, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4174 – Palingen or promatrx, 0.36 mg per 0.25 cc
• Q4175 – Miroderm, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4176 – Neopatch or therion, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4177 – Floweramnioflo, 0.1 cc
• Q4178 – Floweramniopatch, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4179 – Flowerderm, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4180 – Revita, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4181 – Amnio wound, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4182 – Transcyte, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4183 – Surgigraft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4184 – Cellesta or cellesta duo, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4185 – Cellesta flowable amnion (25 mg per cc); per 0.5 cc
• Q4186 – Epifix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4187 – Epicord, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4188 – Amnioarmor, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4189 – Artacent ac, 1 mg
• Q4190 – Artacent ac, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4191 – Restorigin, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4192 – Restorigin, 1 cc
• Q4193 – Coll-e-derm, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4194 – Novachor, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4195 – Puraply, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4196 – Puraply am, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4197 – Puraply xt, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4198 – Genesis amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4199 – Cygnus matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4200 – Skin te, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4201 – Matrion, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4202 – Keroxx (2.5g/cc), 1cc
• Q4203 – Derma-gide, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4204 – Xwrap, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4205 – Membrane graft or membrane wrap, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4206 – Fluid flow or fluid gf, 1 cc
• Q4207 – Carbon life, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4208 – Novafix, per square cenitmeter (add-on, list separately in addition to primary procedure)
• Q4209 – Surgraft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4211 – Amnion bio or axobiomembrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4212 – Allogen, per cc
• Q4213 – Ascent, 0.5 mg
• Q4214 – Cellesta cord, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4215 – Axolotl ambient or axolotl cryo, 0.1 mg
• Q4216 – Artacent cord, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4217 – Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4218 – Surgicord, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4219 – Surgigraft-dual, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4220 – Bellacell hd or surederm, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4221 – Amniowrap2, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4222 – Progenamatrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4223 – Dermabind sl optic, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4224 – Human health factor 10 amniotic patch (hhf10-p), per square centimeter (add-on, list separately in addition to primary procedure)
• Q4225 – Amniobind or dermabind tl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4226 – Myown skin, includes harvesting and preparation procedures, per square centimeter
• Q4227 – Amniocore, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4229 – Cogenex amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4230 – Cogenex flowable amnion, per 0.5 cc
• Q4232 – Corplex, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4233 – Surfactor or nudyn, per 0.5 cc
• Q4234 – Xcellerate, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4235 – Amniorepair or altiply, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4236 – Carepatch, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4237 – Cryo-cord, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4238 – Derm-maxx, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4239 – Amnio-maxx or amnio-maxx lite, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4240 – Corecyte, for topical use only, per 0.5 cc
• Q4241 – Polycyte, for topical use only, per 0.5 cc
• Q4242 – Amniocyte plus, per 0.5 cc
• Q4243 – Amchomatrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4245 – Amniotext, per cc
• Q4246 – Coretext or protext, per cc
• Q4247 – Amniotext patch, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4248 – Dermacyte amniotic membrane allograft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4249 – Amniply, for topical use only, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4250 – Amnioamp-mp, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4251 – Vim, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4252 – Vendaje, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4253 – Zenith amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4254 – Novafix dl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4255 – Reguard, for topical use only, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4256 – Mlg-complete, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4257 – Relese, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4258 – Enverse, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4259 – Celera dual layer or celera dual membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4260 – Signature apatch, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4261 – Tag, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4262 – Dual layer impax membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4263 – Surgraft tl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4264 – Cocoon membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4265 – Neostim tl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4266 – Neostim membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4267 – Neostim dl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4268 – Surgraft ft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4269 – Surgraft xt, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4270 – Complete sl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4271 – Complete ft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4272 – Esano a, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4273 – Esano aaa, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4274 – Esano ac, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4275 – Esano aca, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4276 – Orion, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4278 – Epieffect, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4279 – Vendaje ac, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4280 – Xcell amnio matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4281 – Barrera sl or barrera dl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4282 – Cygnus dual, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4283 – Biovance tri-layer or biovance 3l, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4284 – Dermabind sl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4285 – Nudyn dl or nudyn dl mesh, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4286 – Nudyn sl or nudyn slw, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4287 – Dermabind dl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4288 – Dermabind ch, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4289 – Revoshield + amniotic barrier, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4290 – Membrane wrap-hydro, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4291 – Lamellas xt, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4292 – Lamellas, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4293 – Acesso dl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4294 – Amnio quad-core, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4295 – Amnio tri-core amniotic, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4296 – Rebound matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4297 – Emerge matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4298 – Amniocore pro, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4299 – Amniocore pro+, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4300 – Acesso tl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4301 – Activate matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4302 – Complete aca, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4303 – Complete aa, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4304 – Grafix plus, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4305 – American amnion ac tri-layer, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4306 – American amnion ac, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4307 – American amnion, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4308 – Sanopellis, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4309 – Via matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4310 – Procenta, per 100 mg
• Q4311 – Acesso, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4312 – Acesso ac, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4313 – Dermabind fm, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4314 – Reeva ft, per square cenitmeter (add-on, list separately in addition to primary procedure)
• Q4315 – Regenelink amniotic membrane allograft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4316 – Amchoplast, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4317 – Vitograft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4318 – E-graft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4319 – Sanograft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4320 – Pellograft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4321 – Renograft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4322 – Caregraft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4323 – Alloply, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4324 – Amniotx, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4325 – Acapatch, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4326 – Woundplus, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4327 – Duoamnion, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4328 – Most, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4329 – Singlay, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4330 – Total, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4331 – Axolotl graft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4332 – Axolotl dualgraft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4333 – Ardeograft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4334 – Amnioplast 1, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4335 – Amnioplast 2, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4336 – Artacent c, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4337 – Artacent trident, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4338 – Artacent velos, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4339 – Artacent vericlen, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4340 – Simpligraft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4341 – Simplimax, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4342 – Theramend, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4343 – Dermacyte ac matrix amniotic membrane allograft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4344 – Tri-membrane wrap, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4345 – Matrix hd allograft dermis, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4346 – Shelter dm matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4347 – Rampart dl matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4348 – Sentry sl matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4349 – Mantle dl matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4350 – Palisade dm matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4351 – Enclose tl matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4352 – Overlay sl matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4353 – Xceed tl matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4354 – Palingen dual-layer membrane and dual-layer palingen x-membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4355 – Abiomend xplus membrane and abiomend xplus hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4356 – Abiomend membrane and abiomend hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4357 – Xwrap plus, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4358 – Xwrap dual, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4359 – Choriply, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4360 – Amchoplast fd, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4361 – Epixpress, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4362 – Cygnus disk, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4363 – Amnio burgeon membrane and hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4364 – Amnio burgeon xplus membrane and xplus hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4365 – Amnio burgeon dual-layer membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4366 – Dual layer amnio burgeon x-membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4367 – Amniocore sl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4368 – Amchothick, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4369 – Amnioplast 3, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4370 – Aeroguard, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4371 – Neoguard, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4372 – Amchoplast excel, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4373 – Membrane wrap lite, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4375 – Duograft ac, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4376 – Duograft aa, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4377 – Trigraft ft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4378 – Renew ft matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4379 – Amniodefend ft matrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4380 – Advograft one, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4382 – Advograft dual, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4383 – Axolotl graft ultra, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4384 – Axolotl dualgraft ultra, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4385 – Apollo ft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4386 – Acesso trifaca, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4387 – Neothelium ft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4388 – Neothelium 4l, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4389 – Neothelium 4l+, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4390 – Ascendion, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4391 – Amnioplast double, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4392 – Grafix duo, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4393 – Surgraft ac, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4394 – Surgraft aca, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4395 – Acelagraft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4396 – Natalin, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4397 – Summit aaa, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4398 – Summit ac, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4399 – Summit fx, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4400 – Polygon3 membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4401 – Absolv3 membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4402 – Xwrap 2.0, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4403 – Xwrap dual plus, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4404 – Xwrap hydro plus, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4405 – Xwrap fenestra plus, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4406 – Xwrap fenestra, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4407 – Xwrap tribus, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4408 – Xwrap hydro, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4409 – Amniomatrixf3x, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4410 – Amchomatrixdl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4411 – Amniomatrixf4x, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4412 – Choriofix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4413 – Cygnus solo, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4414 – Simplichor, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4415 – Alexiguard sl-t, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4416 – Alexiguard tl-t, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4417 – Alexiguard dl-t, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4418 – Biolab membrane wrap flow, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4419 – Biolab membrane wrap lite flow, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4420 – Nuform, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4421 – Biolab membrane wrap solo, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4422 – A/c wrap, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4423 – Biolab tri-membrane wrap flow, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4424 – Revive ft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4425 – Revive tl, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4426 – Dermabind tl + or dermabind tl x, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4427 – Dermabind dl n or dermabind dl + or dermabind dl x, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4428 – Dermabind sl n or dermabind sl + or dermabind sl x, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4429 – Dermabind ch n or dermabind ch x, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4431 – Pma skin substitute product, not otherwise specified (list in addition to primary procedure)
• Q4432 – 510(k) skin substitute product, not otherwise specified (list in addition to primary procedure)
• Q4433 – 361 hct/p skin substitute product, not otherwise specified (list in addition to primary procedure)
• Q4435 – Renati membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4436 – Renati ac membrane, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4437 – Revival ac, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4438 – Pretect, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4439 – Instagraft, per square centimeter (add-on, list separately in addition to primary procedure)
• Q4440 – Curamatrix, per square centimeter (add-on, list separately in addition to primary procedure)
• Q5001 – Hospice or home health care provided in patient's home/residence
• Q5002 – Hospice or home health care provided in assisted living facility
• Q5003 – Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)
• Q5004 – Hospice care provided in skilled nursing facility (snf)
• Q5005 – Hospice care provided in inpatient hospital
• Q5006 – Hospice care provided in inpatient hospice facility
• Q5007 – Hospice care provided in long term care facility
• Q5008 – Hospice care provided in inpatient psychiatric facility
• Q5009 – Hospice or home health care provided in place not otherwise specified (nos)
• Q5010 – Hospice home care provided in a hospice facility
• Q5098 – Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg
• Q5099 – Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg
• Q5100 – Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg
• Q5101 – Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
• Q5103 – Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg
• Q5104 – Injection, infliximab-abda, biosimilar, (renflexis), 10 mg
• Q5105 – Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units
• Q5106 – Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
• Q5107 – Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
• Q5108 – Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
• Q5110 – Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
• Q5111 – Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
• Q5112 – Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg
• Q5113 – Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg
• Q5114 – Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg
• Q5115 – Injection, rituximab-abbs, biosimilar, (truxima), 10 mg
• Q5116 – Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg
• Q5117 – Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
• Q5118 – Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg
• Q5119 – Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg
• Q5120 – Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg
• Q5121 – Injection, infliximab-axxq, biosimilar, (avsola), 10 mg
• Q5122 – Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
• Q5123 – Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
• Q5124 – Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
• Q5125 – Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
• Q5126 – Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
• Q5127 – Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
• Q5128 – Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
• Q5129 – Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg
• Q5130 – Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
• Q5133 – Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
• Q5134 – Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg
• Q5135 – Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg
• Q5136 – Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg
• Q5137 – Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg
• Q5138 – Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg
• Q5140 – Injection, adalimumab-fkjp, biosimilar, 1 mg
• Q5141 – Injection, adalimumab-aaty, biosimilar, 1 mg
• Q5142 – Injection, adalimumab-ryvk biosimilar, 1 mg
• Q5143 – Injection, adalimumab-adbm, biosimilar, 1 mg
• Q5144 – Injection, adalimumab-aacf (idacio), biosimilar, 1 mg
• Q5145 – Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg
• Q5146 – Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg
• Q5147 – Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg
• Q5148 – Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
• Q5149 – Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg
• Q5150 – Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg
• Q5151 – Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg
• Q5152 – Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg
• Q5153 – Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg
• Q5154 – Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg
• Q5155 – Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg
• Q5156 – Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg
• Q5157 – Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg
• Q5158 – Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg
• Q5159 – Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg
• Q5160 – Injection, bevacizumab-nwgd (jobevne), biosimilar, 10 mg
• Q5161 – Injection, denosumab-kyqq (aukelso/bosaya), biosimilar, 1 mg
• Q5162 – Injection, denosumab-nxxp (bildyos/bilprevda), biosimilar, 1 mg
• Q5164 – Injection, ustekinumab-hmny (starjemza), biosimilar, 1 mg
• Q5165 – Injection, denosumab-mobz (oziltus), biosimilar, 1 mg
• Q5166 – Injection, denosumab-desu (osvyrti/jubereq), biosimilar, 1 mg
• Q5167 – Injection, denosumab-qbde (enoby/xtrenbo), biosimilar, 1 mg
• Q5168 – Injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mg
• Q5169 – Injection, pegfilgrastim-unne (armlupeg), biosimilar, 0.5 mg
• Q5170 – Injection, aflibercept-boav (eydenzelt), biosimilar, 1 mg
• Q5171 – Injection, denosumab-mobz (boncresa), biosimilar, 1 mg
• Q5172 – Injection, filgrastim-laha (filkri), biosimilar, 1 microgram
• Q5173 – Injection, denosumab-adet (ponlimsi), biosimilar, 1 mg
• Q9001 – Assessment by chaplain services
• Q9002 – Counseling, individual, by chaplain services
• Q9003 – Counseling, group, by chaplain services
• Q9004 – Department of veterans affairs whole health partner services
• Q9950 – Injection, sulfur hexafluoride lipid microspheres, per ml
• Q9951 – Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
• Q9953 – Injection, iron-based magnetic resonance contrast agent, per ml
• Q9954 – Oral magnetic resonance contrast agent, per 100 ml
• Q9955 – Injection, perflexane lipid microspheres, per ml
• Q9956 – Injection, octafluoropropane microspheres, per ml
• Q9957 – Injection, perflutren lipid microspheres, per ml
• Q9958 – High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
• Q9959 – High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
• Q9960 – High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
• Q9961 – High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
• Q9962 – High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
• Q9963 – High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
• Q9964 – High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
• Q9965 – Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
• Q9966 – Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
• Q9967 – Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
• Q9968 – Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
• Q9982 – Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
• Q9983 – Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
• Q9991 – Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
• Q9992 – Injection, buprenorphine extended-release (sublocade), greater than 100 mg
• Q9996 – Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
• Q9997 – Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg
• Q9998 – Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
• Q9999 – Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg

Discontinued Q codes

• Q0174 – Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimenDiscontinued December 31, 2025
• Q0220 – Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mgDiscontinued December 12, 2024
• Q0221 – Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mgDiscontinued December 12, 2024
• Q0222 – Injection, bebtelovimab, 175 mgDiscontinued December 12, 2024
• Q0239 – Injection, bamlanivimab-xxxx, 700 mgDiscontinued April 16, 2021
• Q0240 – Injection, casirivimab and imdevimab, 600 mgDiscontinued December 12, 2024
• Q0243 – Injection, casirivimab and imdevimab, 2400 mgDiscontinued December 12, 2024
• Q0244 – Injection, casirivimab and imdevimab, 1200 mgDiscontinued December 12, 2024
• Q0245 – Injection, bamlanivimab and etesevimab, 2100 mgDiscontinued December 13, 2023
• Q0247 – Injection, sotrovimab, 500 mgDiscontinued December 12, 2024
• Q0516 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-daysDiscontinued December 31, 2024
• Q0517 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-daysDiscontinued December 31, 2024
• Q0518 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-daysDiscontinued December 31, 2024
• Q0519 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-daysDiscontinued December 31, 2024
• Q0520 – Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-daysDiscontinued December 31, 2024
• Q2017 – Injection, teniposide, 50 mgDiscontinued December 31, 2025
• Q2040 – Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusionDiscontinued December 31, 2018
• Q4100 – Skin substitute, not otherwise specifiedDiscontinued December 31, 2025
• Q4106 – Dermagraft, per square centimeterDiscontinued December 31, 2025
• Q4119 – Matristem wound matrix, per square centimeterDiscontinued December 31, 2016
• Q4120 – Matristem burn matrix, per square centimeterDiscontinued December 31, 2016
• Q4129 – Unite biomatrix, per square centimeterDiscontinued December 31, 2016
• Q4131 – Epifix or epicord, per square centimeterDiscontinued December 31, 2018
• Q4172 – Puraply or puraply am, per square centimeterDiscontinued December 31, 2018
• Q4210 – Axolotl graft or axolotl dualgraft, per square centimeterDiscontinued June 30, 2024
• Q4228 – Bionextpatch, per square centimeterDiscontinued September 30, 2021
• Q4231 – Corplex p, per ccDiscontinued March 31, 2025
• Q4244 – Procenta, per 200 mgDiscontinued March 31, 2024
• Q4277 – Woundplus membrane or e-graft, per square centimeterDiscontinued June 30, 2024
• Q5102 – Injection, infliximab, biosimilar, 10 mgDiscontinued March 31, 2018
• Q5109 – Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mgDiscontinued December 31, 2025
• Q5131 – Injection, adalimumab-aacf (idacio), biosimilar, 20 mgDiscontinued December 31, 2024
• Q5132 – Injection, adalimumab-afzb (abrilada), biosimilar, 10 mgDiscontinued December 31, 2024
• Q5139 – Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mgDiscontinued March 31, 2025
• Q9969 – Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study doseDiscontinued December 31, 2025
• Q9970 – Injection, ferric carboxymaltose, 1mgDiscontinued December 31, 2014
• Q9972 – Injection, epoetin beta, 1 microgram, (for esrd on dialysis)Discontinued December 31, 2014
• Q9973 – Injection, epoetin beta, 1 microgram, (non-esrd use)Discontinued December 31, 2014
• Q9974 – Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mgDiscontinued December 31, 2014
• Q9975 – Injection, factor viii fc fusion protein (recombinant), per iuDiscontinued December 31, 2015
• Q9976 – Injection, ferric pyrophosphate citrate solution, 0.1 mg of ironDiscontinued December 31, 2015
• Q9977 – Compounded drug, not otherwise classifiedDiscontinued December 31, 2015
• Q9978 – Netupitant 300 mg and palonosetron 0.5 mgDiscontinued December 31, 2015
• Q9979 – Injection, alemtuzumab, 1 mgDiscontinued December 31, 2015
• Q9980 – Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mgDiscontinued December 31, 2016
• Q9981 – Rolapitant, oral, 1 mgDiscontinued December 31, 2016
• Q9984 – Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mgDiscontinued December 31, 2017
• Q9985 – Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mgDiscontinued December 31, 2017
• Q9986 – Injection, hydroxyprogesterone caproate, (makena), 10 mgDiscontinued December 31, 2017
• Q9987 – Pathogen(s) test for plateletsDiscontinued December 31, 2017
• Q9988 – Platelets, pheresis, pathogen-reduced, each unitDiscontinued December 31, 2017
• Q9989 – Ustekinumab, for intravenous injection, 1 mgDiscontinued December 31, 2017
• Q9993 – Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mgDiscontinued December 31, 2018
• Q9994 – In-line cartridge containing digestive enzyme(s) for enteral feeding, eachDiscontinued December 31, 2018
• Q9995 – Injection, emicizumab-kxwh, 0.5 mgDiscontinued December 31, 2018